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Mammalian cells express four different plasma membrane Ca2+ ATPases. Two of them (PMCA1 and PMCA4) are expressed 
ubiquitously, and are considered housekeeping isoforms. Two (PMCA2 and PMCA4) have tissue restricted distribution. They 
are abundantly expressed in the brain and in nervous tissue-derived cell types. The primary transcripts of all PMCAs undergo 
alternative splicing, generating a large number of additional isoforms. Splicing occurs at site A, in the N-terminal moiety of the 
pump, and at site C, within the C-terminal calmodulin binding domain: The pumps are canonical targets of calmodulin stimu-
lation. The site C insertion leads to a truncation of the pump about 50 residues short of the original C-terminal. One of the 
pumps (PMCA2) has special properties: It displays high activity even in the absence of the natural activator calmodulin, and 
has a particularly complex pattern of alternative splicing at both sites A and C. A variant of the PMCA2 pump containing an 
insert at site A and truncated C-terminally is the resident isoform of the pump in the stereocilia of hair cells of the inner ear. It 
exports Ca2+ to the endolymph that bathes the stereocilia less efficiently than the full length, non-inserted PMCA2 pump. The 
proper functioning of hair cells demands the precise maintenance of the Ca2+ balance between hair cells and the endolymph. 
Disturbances in the balance affect the process of mechano-electrical transduction, which depends on the ability of the stereo-
ciliar bundle to deflect in response to sound waves. The tip links that organize the bundle are formed by the Ca2+ binding pro-
tein cadherin 23 and by protocadherin 15: Disturbances of the Ca2+ binding by cadherin 23 and/or of the ability of the PMCA2 
variant of the stereocilia to export Ca2+ to the endolymph generate hearing loss phenotypes. Such phenotypes have now been 
described in mice and humans. In some cases they are linked to mutations of both cadherin 23 and the PMCA2 pump, but in 
other cases they may be generated by mutations of particular severity in only one of the two proteins. The PMCA2 defect that 
leads to deafness has now been analyzed molecularly: It affects the long range, unstimulated ability of PMCA2 to export Ca2+. 
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Separate genes, located in four different chromosomes, code 
for the four basic isoforms of the plasma membrane calcium 
ATPase (PMCA pump) in mammals. These ATPases are 
134 kD proteins, organized in the plasma membrane with 10 
transmembrane domains and a long C-terminal tail that 
contains a calmodulin binding domain. The primary tran-
script of each one of the four basic isoforms undergoes al-
ternative splicing, increasing the number of PMCA pump 
variants to over 30 [1]. Two of the four basic gene products 
are distributed ubiquitously in mammalian tissues (PMCA1 
and PMCA4): They are thus considered as housekeeping 
isoforms (however, PMCA4 could also have a specific role 
in some cell types, e.g., the spermatozoa [2]). PMCA2 and 
PMCA3 are expressed in a much more limited range of tis-
sues, such as the nervous system. Alternative splicing oc-
curs at two sites in the pump structure: Site A is located in 
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the cytosolic loop that connects transmembrane domains 2 
and 3, site C within the C-terminal calmodulin binding do-
main. The insert(s) at site A are in frame, those at site C are 
not, and generate a premature stop codon that truncates the 
pump some 50 residues short of the original C-terminal. The 
PMCA pump is a classical target of calmodulin stimulation: 
Its canonical C-terminal calmodulin binding domain folds 
over in the resting state to bind to the two first cytosolic 
loops [3,4], maintaining the pump in an auto-inhibited state 
which is relieved by the binding of calmodulin to its domain. 
The stimulation of the activity of the pump has been studied 
in detail using isoforms 1 and 4, which were the first to be 
purified [5]. Calmodulin decreases the Ca2+ Km of the pump 
from 5−10 to about 0.5 µmol L−1, and raises its Vmax 5 or 6 
folds. Its binding affinity (Kd) for the pump is highest in 
PMCA2 (2−4 nmol L−1) intermediate in PMCA3 (8 nmol 
L−1) and lowest in PMCA1 and 4 (30−50 nmol L−1) [1].  
The splicing operation inserts a single exon (36−42 bp) at 
site A in isoforms 1, 2, and 3, and up to 3 exons in PMCA2. 
According to the most widely used nomenclature, the pump 
variant without site A inserts is designated as variant z, that 
with one insert as variant x, that with two inserts as variant y, 
and that with three inserts as variant w: Variants y and w 
only concern PMCA2 [1]. At site C the splicing operation 
inserts one exon in the transcript of PMCA1, PMCA4, and 
PMCA3. The insertion occurs piecemeal, leading to tvariant 
a when the full exon is inserted, and to variant b when no 
insertion occurs. In the case of PMCA2, splicing at site C 
includes or excludes two, not one, novel exons: As in the 
other isoforms, the PMCA2 variant without site C inserts is 
designated as b, that with both exons (172 and 55 bp, re-
spectively) inserted as a [1]. As mentioned, the site C inser-
tions are not in frame, and generate truncated forms of the 
pump. Not much is known on the functional activity of the 
spliced pump variants; however, as could be predicted by 
the truncation of the calmodulin binding domain, the a var-
iants have decreased affinity for calmodulin.   
1  The PMCA2 pump 
The unique complexity of the splicing operation in PMCA2 
is not the only property that sets this isoform apart from the 
other three. Studies on the sensitivity to calmodulin show 
that PMCA2 has peculiarly high activity in its absence [6,7]. 
Table 1 shows that calmodulin stimulates the activity of 
PMCA4 at saturating Ca2+ 4−5 folds, but that of PMCA2 
only about 1.3−1.4 folds. PMCA2 is thus able to efficiently 
pump Ca2+ even in the absence of the natural activator cal-
modulin. In the cell environment, its Ca2+ exporting activity 
will thus be somehow protected from variations in the con-
centration of the activator in its vicinity. The reasons for the 
peculiarly high activity of PMCA2 in the absence of cal-
modulin are still obscure.In spite of the very high affinity 
for calmodulin, no tightly bound activator was found in pu-
rified PMCA2 preparations. Possibly, the interaction of the 
C-terminal calmodulin binding domain of PMCA 2 with the 
auto-inhibitory sites close to the active site of the enzyme 
would be less efficient than in the other three isoforms, 
making PMCA2 constitutively active.  
As mentioned, PMCA2 is abundantly expressed in the 
nervous tissue. Most brain regions express large amounts of 
it, as do cells of nervous derivation, such as the hair cells of 
the Corti Organ of the inner ear. Hair cells are characterized 
by stereocilia that protrude into the endolymph, an extra-
cellular fluid that has a peculiarly low Ca2+ concentration 
(~20 µmol L−1). PMCA2 is highly concentrated in the ste-
reociliar plasma membrane, and exports Ca2+ to it. Evident-
ly, the special properties of PMCA2 have been selected to 
satisfy the Ca2+ homeostasis requirements of a fluid as spe-
cial as the endolymph. However, the properties of the nor-
mal zb variant of PMCA2 were perhaps not completely ad-
equate for the Ca2+ homeostasis requirements of the endo-
lymph: The resident pump of the stereocilia is thus  the wa 
truncated variant of PMCA2 [8], which has lower Ca2+ ex-
porting activity than the non-inserted full length zb variant: 
The experiment shown in Figure 1, which records the activ-
ity of the pumps in the cell environment, shows clearly that 
the truncated form of PMCA2 has lower Ca2+ exporting abil-
ity than the full length, non-spliced variant. 
 
Table 1  Calmodulin stimulation of PMCA2 and PMCA4a) 
 
Ca2+-dependent ATPase activity 
(nmol ATP mg protein−1 min−1) 
−Calmodulin +Calmodulin 
PMCA2 4.21 5.87 
PMCA4 1.45 6.15 
a) From [6] and [7]. 
 
 
Figure 1  Monitoring of cytosolic Ca2+ concentration [Ca2+]c in CHO cells 
transfected with the Ca2+ sensitive recombinant protein aequorin (cytAEQ) 
and splice variants zb and wa of the PMCA2 pump. The Ca2+ transient was 
induced by ATP, a purinergic agonist that liberates inositol-tris-phosphate  
[1]. Full details on the technical details of the experiment are found in [15]. 
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Interest in the presence and function of PMCA2 in the 
hair cells of the inner ear was heightened by the analysis of 
the phenotype of PMCA2 knock out mice [9], which was 
characterized by balance disturbance and hearing loss. The 
study of the vestibular inner hear revealed the absence of 
the otoconia and the progressive degeneration of the hair 
cells beginning 10 days after birth. At about the same time, 
the first spontaneous mice mutation of the PMCA 2 pump 
was described (the deafwaddler G283S mutation [10]), 
which had equilibrium defects and a deafness phenotype. 
Another spontaneous PMCA2 pump mutation that produced 
equilibrium imbalance and hearing loss (the Wriggle 
Sagami mouse [11]) was described shortly afterwards: A 
K412E replacement in the fourth transmembrane domain of 
the pump prevented its correct targeting to the plasma 
membrane of the stereocilia. Following these initial findings, 
the involvement of PMCA2 in the hearing process became a 
topic of intensive studies. It has now led to a better under-
standing of the role of Ca2+ in the physiology of the hair 
cells of the inner ear, and of the fine properties of PMCA2 
in the homeostasis of Ca2+ in hair cells and the endolymph. 
2  Calcium in the hearing process 
Hearing depends on the ability of the inner ear to convert 
the sound waves transmitted through the endolymph into 
signals that are transduced by the hair cells of the Corti or-
gan through the mechanoelectric transduction (MET) pro-
cess. The outer hair cells do not send signals to the acoustic 
area of the brain: They act as mechanosensors that amplify 
the mechanical vibrations of the basilar membrane in re-
sponse to sound. The amplification activates the MET pro-
cess in the inner hair cells that release neurotransmitters to 
afferent dendrites of neurons in the spiral ganglion trigger-
ing action potentials that relay acoustic signals to the brain. 
As mentioned, the endolymph bathes the stereociliar bundle 
of the hair cells, deflecting them in response to sound waves 
to induce the opening of stereocilia channels that mediate 
the penetration of K+ and Ca2+ into the stereociliar cyto-
plasm. Recent work performed under the Ca2+ concentration 
conditions of the endolymph [12] has shown that only about 
0.2% of the total MET current is carried by Ca2+. The very 
low Ca2+ concentration of the endolymph must be very pre-
cisely controlled, as Ca2+ binds reversibly to EF hand motifs 
of cadherin 23, a single pass transmembrane protein that 
protrudes into the endolymph to form, together with proto-
cadherin 15, the tip links that organize the stereociliar bun-
dle to promote their deflection. Ca2+ that enters the stereo-
ciliar cytoplasm through the MET channels would have to 
be continuously exported back to the endolymph by the 
doubly spliced truncated wa variant of PMCA2. Cadherin 
23 and the PMCA2 wa variant are thus two of the compo-
nents which are essential to the correct functioning of the 
MET process of hair cells. Alterations of the Ca2+ homeosta-
sis of the endolymph, and/or the impairment of the ability of 
cadherin 23 to properly bind Ca2+, would disrupt the MET 
process, generating a sensorineural deafness phenotype. 
3  PMCA2 pump defects and hereditary deaf-
ness 
The deafness phenotype in PMCA2 knockout mice and in 
mice carrying the G283S mutation of PMCA2 has already 
been mentioned, but cadherin 23 mutations, as expected, 
can also produce a deafness phenotype [13]. Interest in the 
phenotypes of hereditary deafness linked to disturbances of 
hair cell Ca2+ homeostasis has now grown considerably. 
Such phenotypes have been described in mice and humans 
[10,14−17], and are frequently produced by the combined 
mutations of both proteins. However, it could be expected 
that defects of only one of the two proteins, if particularly 
severe, would be sufficient to generate the deafness pheno-
type: Indeed, mutations in the PMCA that induce deafness 
per se, i.e., without concomitant mutations of cadherin 23 
have been described in mice [16,17]. In turn, a human fam- 
ily has been described in which the deafness phenotype was 
induced by the cadherin 23 mutation, and was only exacer-
bated by a concomitant mutation in the PMCA pump [14]. 
Another human case [15] was of particular interest, since 
one of the parent had a PMCA2 mutation, and the other the 
cadherin 23 mutation. They were both healthy, but the 
deafness phenotype became manifest in a son who carried 
both mutations: a classical digenic mechanism. Figure 2 
summarizes the mutations of PMCA 2 that have so far 
found to induce deafness in mice and humans, and indicates 
the loci of the mutations in the pump molecule. 
The PMCA2 pump defect has so far only been analyzed 
molecularly in three mice and one human case [15−17] 
(Figures 3−5). Based on the type of amino acid substitution, 
defects of different severity could have been expected: For 
instance, the G293S mutation of the human case described 
by Ficarella et al. [15] was located in a portion of the pump 
molecule which was distant from any functionally sensitive 
sites. Its effect on the Ca2+ exporting function of the pump 
was thus relatively minor (Figure 3). By contrast, in the 
Oblivion and Tommy mice (Figures 4 and 5) the mutations 
affected a residue located in the immediate vicinity of the 
active site of the pump, or within one of the transmembrane 
domains: The function of the pump was thus more severely 
affected. Qualitatively, however, the basic defect in all mu-
tations followed the same pattern: The mutated PMCA 2 wa 
pumps expressed in model cells had decreased ability to 
export Ca2+ out of the cell. However, as Figures 3−5 show, 
the defect was not so much in the ability of the mutated 
pumps to immediately control the arrival of a large Ca2+ 
pool, but in the ability to efficiently return the Ca2+ level to 
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Figure 2  A summary of the deafness-inducing PMCA2 pump mutations in which the functional defect of the pump has been documented. The figure also  
shows the locations of the mutations in the pump molecule. 
 
Figure 3  Experimental conditions as in Figure 1, except that the CHO 
cells were transfected with the PMCA2 pump mutants deafwaddler  
(G283S) and G293S. 
 
Figure 4  Experimental conditions as in Figure 1. The CHO cells were  
transfected with the PMCA2 Oblivion mutant (S877F). 
the baseline after the transient, i.e., in the long range ability 
to continuously eject Ca2+. When translated to the hair 
cell-stereocilia situation, these findings would correspond to  
 
Figure 5  Experimental conditions as in Figure 1. The CHO cells were  
transfected with the PMCA2 pump mutant Tommy (E584K). 
the continuously impaired return of the Ca2+ that had en-
tered through the MET channels Ca2+ to the endolymph. 
The expected result of the defect would conceivably be the 
alteration of the homeostasis of Ca2+ in the endolymph, with 
the consequent impairment of the function of the cadherin 23/ 
protocadherin 15 tip links. 
4  Concluding remarks 
The cases of hereditary deafness linked to PMCA2 defects 
are rare, at least when the pump is the only actor affected. 
However, the importance of maintaining the correct Ca2+ 
homeostasis in the endolymph, which is a task of the 
PMCA2 pump, and of the correct concerted functioning of 
PMCA2 and cadherin 23 extend greatly the possible conse-
quences of the malfunction of the pump, i.e., the pump de-
fects could act as modifiers of a much larger range of hear-
ing loss phenotypes, genetic and/or environmental, linked to 
pathological processes affecting hair cells. 
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